id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
artofmedicineimsj-55	Basu, D.; Kumar, H.	SAFETY OF INSULIN DEGLUDEC/INSULIN ASPART IN PATIENTS WITH DIABETES MELLITUS OVER A PERIOD OF 1 YEAR DURING ROUTINE CLINICAL CARE IN INDIA: SMART (STUDY OF MANAGEMENT OF DIABETES WITH RYZODEG™ TREATMENT)	2021	7	.pdf	application/pdf	2258	127	55	Patients previously on IDegAsp therapy or those participating in another study were excluded. Thirty adverse events were reported in 23 patients (2.2%) during the follow-up: two adverse events in two patients were serious with fatal outcomes, which were unrelated to IDegAsp use.	cache/artofmedicineimsj-55.pdf	txt/artofmedicineimsj-55.txt